Live Breaking News & Updates on Abstract Code

Stay updated with breaking news from Abstract code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress

/PRNewswire/ Cytovia Therapeutics, LLC ("Cytovia Therapeutics"), a global biotechnology company focused on harnessing the power of natural killer (NK) cells. ....

United States , New York , Puerto Rico , Israel General , Sankt Peterburg , Hebrew University , Jean Christophe Bories , Isleworth Healthcare Acquisition Corp , York Stem Cell Foundation , Securities Exchange Commission , Congress Center , European Hematology Association , Second Merger Sub , Isleworth Healthcare Sponsor , University Of California San Francisco , First Merger Sub Inc , Cytovia Holdings Inc , Cytovia Therapeutics , Annual European Hematology Association , Messe Wien Exhibition , Abstract Code , Jean Christophe , New York Stem Cell Foundation , California San Francisco , Cytolynx Therapeutics , Greater China ,

Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting

/PRNewswire/ Dizal (SSE: 688192) will present the data from an ongoing phase I/II study of golidocitnib, a selective JAK1 inhibitor, in refractory or. ....

Seog Kim , Xiaolin Zhang , International Conference On Malignant Lymphoma , Samsung Medical Center , European Hematology Association , Business Development , Hybrid Congress , Track Designation , Malignant Lymphoma , Chief Executive Officer , Fast Track , Aggressive Lymphoma , Abstract Code , Won Seog Kim , Samsung Medical , Dizal Pharmaceutical ,

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus to present clinical data at EHA Congress

Investegate announcements from Syncona Limited, Autolus to present clinical data at EHA Congress ....

City Of , United Kingdom , United States , Olivia Manser , Hodgkin Lymphoma , Martin Murphy , Sara Ghorashian , Claire Roddie , Collins Fergus Witt , Julia Wilson , Susana Noonan , Hall Strauss , Kate Cwynarski , Syncona Investment Management , European Hematology Association Congress , Exchange Commission On , European Hematology Association , Sa Noonan Communications , Exchange Commission , Autolus Therapeutics Plc Nasdaq , Syncona Ltd , Autolus Therapeutics Plc , Chief Executive Officer , Syncona Investment Management Limited , Syncona Limited , Julia Bradshaw ,

Autolus Therapeutics to Present Four Clinical Data Updates

- AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma- AUTO1/22: oral presentation on initial experience in r/r pediatric. ....

United Kingdom , United States , City Of , Olivia Manser , Susana Noonan , Julia Wilson , Hall Strauss , Sara Ghorashian , Kate Cwynarski , Claire Roddie , Exchange Commission , Exchange Commission On , European Hematology Association , Sa Noonan Communications , Christian Itin , Chief Executive Officer , Abstract Code , B Cell Non Hodgkin , Lymphocytic Leukemia , Small Lymphocytic Lymphoma , Autolus Therapeutics , Private Securities Litigation Reform Act , Autolu Annual Report , Nasdaq Autl , Autolus Limited , Autolus Therapeutics ,

Aptose to Hold KOL Event and Corporate Update Thursday, June 2nd

12.05.2022 - Clinical Updates for HM43239 and Luxeptinib Poster Presentation for HM43239 is Scheduled for June 10th at EHA2022 Hybrid Congress SAN DIEGO and TORONTO, May 12, 2022 (GLOBE NEWSWIRE) - Aptose Biosciences Inc. (“Aptose” or the “Company”) . ....

Aptose Biosciences , Susan Pietropaolo , Rafael Bejar , Lifesci Advisors , Aptose Biosciences Inc , Corporate Communications Investor Relations , Aptose Corporate Update , Webcast Link , Austria June , Acquired Resistance , Acute Myeloid Leukemia Models , Abstract Code , Sci Advisors , Managing Director ,